RKRezaul Karim

Rezaul Karim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rezaul Karim has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Large Language Models to Knowledge Graphs for Biomarker Discovery in Cancer

    by Rezaul Karim, Lina Molinas Comet, Shajalal, Oya Deniz Beyan, Dietrich Rebholz-Schuhmann, Stefan Decker

    Domain experts often rely on most recent knowledge for apprehending and disseminating specific biological processes that help them design strategies for developing prevention and therapeutic decision-making in various disease scenarios. A challenging scenarios for artificial intelligence (AI) is using biomedical data (e.g., texts, imaging, omics, and clinical) to provide diagnosis and treatment recommendations for cancerous conditions.~Data and knowledge about biomedical entities like cancer, drugs, genes, proteins, and their mechanism is spread across structured (knowledge bases (KBs)) and unstructured (e.g., scientific articles) sources. A large-scale knowledge graph (KG) can be constructed by integrating and extracting facts about semantically interrelated entities and relations. Such a KG not only allows exploration and question answering (QA) but also enables domain experts to deduce new knowledge. However, exploring and querying large-scale KGs is tedious for non-domain users due to their lack of understanding of the data assets and semantic technologies. In this paper, we develop a domain KG to leverage cancer-specific biomarker discovery and interactive QA. For this, we constructed a domain ontology called OncoNet Ontology (ONO), which enables semantic reasoning for validating gene-disease (different types of cancer) relations. The KG is further enriched by harmonizing the ONO, metadata, controlled vocabularies, and biomedical concepts from scientific articles by employing BioBERT- and SciBERT-based information extractors. Further, since the biomedical domain is evolving, where new findings often replace old ones, without having access to up-to-date scientific findings, there is a high chance an AI system exhibits concept drift while providing diagnosis and treatment. Therefore, we fine-tune the KG using large language models (LLMs) based on more recent articles and KBs.


  • Top Cited Papers

    Explainable AI for Bioinformatics: Methods, Tools and Applications

    by Rezaul Karim, Tanhim Islam, Shajalal, Oya Beyan, Christoph Lange, Michael Cochez, Dietrich Rebholz-Schuhmann, Stefan Decker

    Artificial intelligence (AI) systems utilizing deep neural networks and machine learning (ML) algorithms are widely used for solving critical problems in bioinformatics, biomedical informatics and precision medicine. However, complex ML models that are often perceived as opaque and black-box methods make it difficult to understand the reasoning behind their decisions. This lack of transparency can be a challenge for both end-users and decision-makers, as well as AI developers. In sensitive areas such as healthcare, explainability and accountability are not only desirable properties but also legally required for AI systems that can have a significant impact on human lives. Fairness is another growing concern, as algorithmic decisions should not show bias or discrimination towards certain groups or individuals based on sensitive attributes. Explainable AI (XAI) aims to overcome the opaqueness of black-box models and to provide transparency in how AI systems make decisions. Interpretable ML models can explain how they make predictions and identify factors that influence their outcomes. However, the majority of the state-of-the-art interpretable ML methods are domain-agnostic and have evolved from fields such as computer vision, automated reasoning or statistics, making direct application to bioinformatics problems challenging without customization and domain adaptation. In this paper, we discuss the importance of explainability and algorithmic transparency in the context of bioinformatics. We provide an overview of model-specific and model-agnostic interpretable ML methods and tools and outline their potential limitations. We discuss how existing interpretable ML methods can be customized and fit to bioinformatics research problems. Further, through case studies in bioimaging, cancer genomics and text mining, we demonstrate how XAI methods can improve transparency and decision fairness. Our review aims at providing valuable insights and serving as a starting point for researchers wanting to enhance explainability and decision transparency while solving bioinformatics problems. GitHub: https://github.com/rezacsedu/XAI-for-bioinformatics.


  • Multimodal Hate Speech Detection from Bengali Memes and Texts

    by Rezaul Karim, Sumon Kanti Dey, Tanhim Islam, Shajalal, Bharathi Raja Chakravarthi


  • Open Access

    Explainable AI for Bioinformatics: Methods, Tools, and Applications

    by Rezaul Karim, Tanhim Islam, Oya Beyan, Christoph Lange, Michael Cochez, Dietrich Rebholz-Schuhmann, Stefan Decker

    Artificial intelligence (AI) systems utilizing deep neural networks (DNNs) and machine learning (ML) algorithms are widely used for solving important problems in bioinformatics, biomedical informatics, and precision medicine. However, complex DNNs or ML models, which are often perceived as opaque and black-box, can make it difficult to understand the reasoning behind their decisions. This lack of transparency can be a challenge for both end-users and decision-makers, as well as AI developers. Additionally, in sensitive areas like healthcare, explainability and accountability are not only desirable but also legally required for AI systems that can have a significant impact on human lives. Fairness is another growing concern, as algorithmic decisions should not show bias or discrimination towards certain groups or individuals based on sensitive attributes. Explainable artificial intelligence (XAI) aims to overcome the opaqueness of black-box models and provide transparency in how AI systems make decisions. Interpretable ML models can explain how they make predictions and the factors that influence their outcomes. However, most state-of-the-art interpretable ML methods are domain-agnostic and evolved from fields like computer vision, automated reasoning, or statistics, making direct application to bioinformatics problems challenging without customization and domain-specific adaptation. In this paper, we discuss the importance of explainability in the context of bioinformatics, provide an overview of model-specific and model-agnostic interpretable ML methods and tools, and outline their potential caveats and drawbacks. Besides, we discuss how to customize existing interpretable ML methods for bioinformatics problems. Nevertheless, we demonstrate how XAI methods can improve transparency through case studies in bioimaging, cancer genomics, and text mining.


  • Open Access

    Adversary-Aware Multimodal Neural Networks for Cancer Susceptibility Prediction From Multiomics Data

    by Rezaul Karim, Tanhim Islam, Christoph Lange, Dietrich Rebholz-Schuhmann, Stefan Decker

    Artificial intelligence (AI) systems are increasingly used in health and personalized care. However, the adoption of data-driven approaches in many clinical settings has been hampered due to their inability to perform in a reliable and safe manner to leverage accurate and trustworthy diagnoses. A critical and challenging usage scenario for AI is aiding the treatment of cancerous conditions. Providing accurate diagnosis for cancer is a challenging problem in precision oncology. Although machine learning (ML)-based approaches are very effective at cancer susceptibility prediction and subsequent treatment recommendations, ML models can be vulnerable to adversarial attacks. Since adversarially weak models can lead to wrong clinical recommendations, such vulnerabilities is more critical – especially when AI-guided systems are used to aid medical doctors. Therefore, it is indispensable that healthcare professionals employ trustworthy AI tools for predicting and assessing disease risks and progression. In this paper, we propose an adversary-aware multimodal convolutional autoencoder (MCAE) model for cancer susceptibility prediction from multi-omics data consisting of copy number variations (CNVs), miRNA expression, and gene expression (GE). Based on different representational learning techniques, the MCAE model learns multimodal feature representations from multi-omics data, followed by classifying the patient cohorts into different cancer types on multimodal embedding space that exhibit similar characteristics in end-to-end setting. To make the MCAE model robust to adversaries and to provide consistent diagnosis, we formulate robustness as a property, such that predictions remain stable with regard to small variations in the input. We study different adversarial attacks scenarios and take both proactive and reactive measures (e.g., adversarial retraining and identification of adversarial inputs). Experiment results show that the MCAE model based on latent representation concatenation (LRC) exhibits high confidence at predicting cancer types, giving an average precision and Matthews correlation coefficient (MCC) scores of 0.9625 and 0.8453, respectively and shows higher robustness when compared and tested with state-of-the-art approaches against different attack scenarios w.r.t. ERM and CLEVER scores. Overall, our study suggests that a well-fitted and adversarially robust model can provide consistent and reliable diagnosis for cancer.


  • Open Access

    DeepKneeExplainer: Explainable Knee Osteoarthritis Diagnosis From Radiographs and Magnetic Resonance Imaging

    by Rezaul Karim, Jiao Jiao, Till Dohmen, Michael Cochez, Oya Beyan, Dietrich Rebholz-Schuhmann, Stefan Decker

    Osteoarthritis (OA) is a degenerative joint disease, which significantly affects middle-aged and elderly people. Although primarily identified via hyaline cartilage change based on medical images, technical bottlenecks like noise, artifacts, and modality impose an enormous challenge on high-precision, objective, and efficient early quantification of OA. Owing to recent advancements, approaches based on neural networks (DNNs) have shown outstanding success in this application domain. However, due to nested non-linear and complex structures, DNNs are mostly opaque and perceived as black-box methods, which raises numerous legal and ethical concerns. Moreover, these approaches do not have the ability to provide the reasoning behind diagnosis decisions in the way humans would do, which poses an additional risk in the clinical setting. In this paper, we propose a novel explainable method for knee OA diagnosis based on radiographs and magnetic resonance imaging (MRI), which we called DeepKneeExplainer . First, we comprehensively preprocess MRIs and radiographs through the deep-stacked transformation technique against possible noises and artifacts that could contain unseen images for domain generalization. Then, we extract the region of interests (ROIs) by employing U-Net architecture with ResNet backbone. To classify the cohorts, we train DenseNet and VGG architectures on the extracted ROIs. Finally, we highlight class-discriminating regions using gradient-guided class activation maps (Grad-CAM++) and layer-wise relevance propagation (LRP), followed by providing human-interpretable explanations of the predictions. Comprehensive experiments based on the multicenter osteoarthritis study (MOST) cohorts, our approach yields up to 91% classification accuracy, outperforming comparable state-of-the-art approaches. We hope that our results will encourage medical researchers and developers to adopt explainable methods and DNN-based analytic pipelines towards an increasing acceptance and adoption of AI-assisted applications in the clinical practice for improved knee OA diagnoses.


  • Open Access

    Enabling ad-hoc reuse of private data repositories through schema extraction

    by Lars Christoph Gleim, Rezaul Karim, Lukas Zimmermann, Oliver Kohlbacher, Holger Stenzhorn, Stefan Decker, Oya Beyan

    Background: Sharing sensitive data across organizational boundaries is often significantly limited by legal and ethical restrictions. Regulations such as the EU General Data Protection Rules (GDPR) impose strict requirements concerning the protection of personal and privacy sensitive data. Therefore new approaches, such as the Personal Health Train initiative, are emerging to utilize data right in their original repositories, circumventing the need to transfer data. Results: Circumventing limitations of previous systems, this paper proposes a configurable and automated schema extraction and publishing approach, which enables ad-hoc SPARQL query formulation against RDF triple stores without requiring direct access to the private data. The approach is compatible with existing Semantic Web-based technologies and allows for the subsequent execution of such queries in a safe setting under the data provider’s control. Evaluation with four distinct datasets shows that a configurable amount of concise and task-relevant schema, closely describing the structure of the underlying data, was derived, enabling the schema introspection-assisted authoring of SPARQL queries. Conclusions: Automatically extracting and publishing data schema can enable the introspection-assisted creation of data selection and integration queries. In conjunction with the presented system architecture, this approach can enable reuse of data from private repositories and in settings where agreeing upon a shared schema and encoding a priori is infeasible. As such, it could provide an important step towards reuse of data from previously inaccessible sources and thus towards the proliferation of data-driven methods in the biomedical domain.


  • Open Access

    Convolutional Embedded Networks for Population Scale Clustering and Bio-Ancestry Inferencing

    by Rezaul Karim, Michael Cochez, Achille Zappa, Ratnesh Sahay, Dietrich Rebholz-Schuhmann, Oya Beyan, Stefan Decker

    The study of genetic variants(GVs) can help find correlating population groups to identify cohorts that are predisposed to common diseases and explain differences in disease susceptibility and how patients react to drugs. ML algorithms are increasingly being applied to identify interacting GVs to understand their complex phenotypic traits. In this paper, we proposed convolutional embedded networks(CEN) in which we combine two DNN architectures called convolutional embedded clustering(CEC) and convolutional autoencoder(CAE) classifier for clustering individuals and predicting geographic ethnicity based on GVs, respectively. We employed CAE-based representation learning on 95 million GVs from the 1000 genomes and Simons genome diversity projects. Quantitative and qualitative analyses with a focus on accuracy and scalability show that our approach outperforms state-of-the-art approaches such as VariantSpark and ADMIXTURE. In particular, CEC can cluster targeted population groups in 22 hours with an adjusted rand index(ARI) of 0.915, the normalized mutual information(NMI) of 0.92, and the clustering accuracy(ACC) of 89%. Contrarily, the CAE classifier can predict the geographic ethnicity of unknown samples with an F1 and Mathews correlation coefficient(MCC) score of 0.9004 and 0.8245, respectively. To provide interpretations of the predictions, we identify significant biomarkers using gradient boosted trees and SHAP.


  • Open Access

    Deep learning-based clustering approaches for bioinformatics

    by Rezaul Karim, Oya Beyan, Achille Zappa, Ivan G Costa, Dietrich Rebholz-Schuhmann, Michael Cochez, Stefan Decker

    Clustering is central to many data-driven bioinformatics research and serves a powerful computational method. In particular, clustering helps at analyzing unstructured and high-dimensional data in the form of sequences, expressions, texts and images. Further, clustering is used to gain insights into biological processes in the genomics level, e.g. clustering of gene expressions provides insights on the natural structure inherent in the data, understanding gene functions, cellular processes, subtypes of cells and understanding gene regulations. Subsequently, clustering approaches, including hierarchical, centroid-based, distribution-based, density-based and self-organizing maps, have long been studied and used in classical machine learning settings. In contrast, deep learning (DL)-based representation and feature learning for clustering have not been reviewed and employed extensively. Since the quality of clustering is not only dependent on the distribution of data points but also on the learned representation, deep neural networks can be effective means to transform mappings from a high-dimensional data space into a lower-dimensional feature space, leading to improved clustering results. In this paper, we review state-of-the-art DL-based approaches for cluster analysis that are based on representation learning, which we hope to be useful, particularly for bioinformatics research. Further, we explore in detail the training procedures of DL-based clustering algorithms, point out different clustering quality metrics and evaluate several DL-based approaches on three bioinformatics use cases, including bioimaging, cancer genomics and biomedical text mining. We believe this review and the evaluation results will provide valuable insights and serve a starting point for researchers wanting to apply DL-based unsupervised methods to solve emerging bioinformatics research problems.


  • Open Access

    A snapshot neural ensemble method for cancer-type prediction based on copy number variations

    by Rezaul Karim, Ashiqur Rahman, João Bosco Jares, Stefan Decker, Oya Beyan

    An accurate diagnosis and prognosis for cancer are specific to patients with particular cancer types and molecular traits, which needs to address carefully. The discovery of important biomarkers is becoming an important step toward understanding the molecular mechanisms of carcinogenesis in which genomics data and clinical outcomes need to be analyzed before making any clinical decision. Copy number variations (CNVs) are found to be associated with the risk of individual cancers and hence can be used to reveal genetic predispositions before cancer develops. In this paper, we collect the CNVs data about 8000 cancer patients covering 14 different cancer types from The Cancer Genome Atlas. Then, two different sparse representations of CNVs based on 578 oncogenes and 20,308 protein-coding genes, including genomic deletions and duplication across the samples, are prepared. Then, we train Conv-LSTM and convolutional autoencoder (CAE) networks using both representations and create snapshot models. While the Conv-LSTM can capture locally and globally important features, CAE can utilize unsupervised pretraining to initialize the weights in the subsequent convolutional layers against the sparsity. Model averaging ensemble (MAE) is then applied to combine the snapshot models in order to make a single prediction. Finally, we identify most significant CNVs biomarkers using guided-gradient class activation map plus (GradCAM++) and rank top genes for different cancer types. Results covering several experiments show fairly high prediction accuracies for the majority of cancer types. In particular, using protein-coding genes, Conv-LSTM and CAE networks can predict cancer types correctly at least 72.96% and 76.77% of the cases, respectively. Contrarily, using oncogenes gives moderately higher accuracies of 74.25% and 78.32%, whereas the snapshot model based on MAE shows overall 2.5% of accuracy improvement.